Table 3A.7 Disability Weights for Malignant Neoplasms and Their Long-Term Sequelae ,,,,,,,,
Site , ,Stage ,,Mortality stratum (for WHO subregions),,,,
,Diagnosis/therapy ,,,,,,,
,,Control ,Long-term sequela ,A    ,B,C,D/E,
Mouth and oropharynx ,0.09,0.09, ,,,,,
Esophagus ,0.20,0.20, ,,,,,
Stomach ,0.20,0.20, ,,,,,
Colon and rectum ,0.20,0.20,Stoma ,0.09,0.09,0.06,0.02, 
Liver ,0.20,0.20, ,,,,,
Pancreas ,0.20,0.20, ,,,,,
"Trachea, bronchus, and lung ",0.15,0.15, ,,,,,
Melanoma and other skin ,0.05,0.05, ,,,,,
Breast ,0.09,0.09,Mastectomy ,0.03,0.05,0.06,0.08, 
Cervix uteri ,0.08,0.08,Infertility/incontinence ,0.04,0.11,0.13,0.17, 
Corpus uteri ,0.10,0.10,Infertility/incontinence ,0.18,0.18,0.18,0.18, 
Ovary ,0.10,0.10,Infertility/incontinence ,0.18,0.18,0.18,0.18, 
Prostate ,0.13,0.13,Impotence/incontinence ,0.06,0.06,0.06,0.06, 
Bladder ,0.09,0.09, ,,,,,
Non-Hodgkin’s lymphoma ,0.06,0.06, ,,,,,
Hodgkin’s lymphoma ,0.06,0.06, ,,,,,
Leukemia ,0.09,0.09, ,,,,,
Other ,0.09,0.09, ,,,,,
"Sources: Mathers, Vos, and Stevenson 1999; Stouthard and others 1997. ",,,,,,,,
"Note: For all cancer sites, the disability weight is 0.75 for the preterminal metastasis stage, and 0.81 in the terminal stage. For definitions of the mortality strata, see WHO 2002e. ",,,,,,,,
,,,,,,,,